His lab is focusing on refining the alanine-scanning assay to some essential residues which will precisely distinguish in between fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological prognosis, and possibly for blood screening of tauopathies.Given that the top on the web artwork